Oculus Innovative Sciences (OCLS) – Major News
-
Oculus Innovative Sciences (OCLS) Misses Q2 EPS by 12c
-
Oculus Innovative Sciences (OCLS) Misses Q1 EPS by 5c
-
Oculus Innovative Sciences (OCLS) Tops Q2 EPS by 14c
-
Oculus Innovative Sciences (OCLS) Misses Q1 EPS by 51c
-
Oculus Innovative Sciences (OCLS) Posts Q4 EPS of 99c
-
Oculus Innovative Sciences, Inc. (OCLS) Posts Q2 Loss of 21c/Share
-
Oculus Innovative Sciences (OCLS) Reports In-Line Q1 Loss of 26c/Share
-
Oculus Innovative Sciences, Inc. (OCLS) Posts Q4 Loss of 44c/Share
-
Oculus Innovative Sciences, Inc. (OCLS) Posts Q3 Loss of 5c/Share
-
Oculus Innovative Sciences, Inc. (OCLS) Posts Q3 Loss of 5c/Share
-
Oculus Innovative Sciences, Inc. (OCLS) Tops Q1 EPS by 3c
-
Oculus Innovative Sciences (OCLS) Tops Q4 EPS by 2c
-
Oculus Innovative Sciences, Inc. (OCLS) Reports Q3 Loss of $0.09
-
Oculus Innovative Sciences, Inc. (OCLS) Posts Q2 Net Loss of $0.03
-
Oculus Innovative Sciences, Inc. (OCLS) Posts Q1 EPS Loss of $0.08, Revenues Fall Inline
-
Oculus Innovative Sciences (OCLS) Posts Narrower than Expected Q4 Loss
-
Oculus Innovative Sciences (OCLS) Misses Q3 EPS by 1c
-
Oculus Innovative (OCLS) Posts Q4 Loss of $0.06, Narrower Y/Y
-
Oculus Innovative (OCLS) Tops Q3 EPS by 2c
-
Oculus Innovative Sciences (OCLS) Reports Q4 Loss of $0.13
-
Oculus Innovative (OCLS) Receives FDA 510(k) Okay
-
OCULUS INNOVATIVE SCIENCES (OCLS) Reports Mixed Q3 Results
-
Oculus Innovative (OCLS) Surges on Chinese Regulatory Approval
Back to OCLS Stock Lookup